Jason Adelstone is a seasoned business lawyer, international policy advisor, and problem solver. Based in Denver, Colorado, he provides domestic and international legal counsel to a diverse clientele, including entrepreneurs, corporations, religious organizations, and federal and international cannabis operators. His practice spans corporate law, international policy, and cannabis regulatory compliance, helping clients navigate the complexities of the global cannabis industry and beyond.
On May 22, the states of Nebraska, Indiana, and Louisiana filed a Petition for Review in the United States Court of Appeals for the District of Columbia Circuit (“DC Circuit”) challenging the Acting Attorney General’s (“AG”) final agency action moving FDA-approved and state-licensed marijuana into Schedule III of the Controlled Substances Act (“CSA”). The DC
Since acting Attorney General Todd Blanch announced that state-legal medical marijuana would move to Schedule III, the commentary has been relentless — hot takes, doomsayers, and self-proclaimed experts flooding LinkedIn with conflicting interpretations. Much of it is speculative, overstated, and uneducated. This piece cuts through the noise and responds to the questions I have fielded
For state-licensed medical marijuana operators, a narrow and potentially transformative window has opened--one that could position your business for future interstate and even global trade. While the Acting Attorney General’s rescheduling order is likely to face legal challenges, the immediate reality is this: you have a 60-day opportunity to act. As of yesterday, April 28,
U.S. joins much of the world in acknowledging medical marijuana The U.S. has joined much of the world in acknowledging medical marijuana. Let international trading begin! Effective April 28, 2026, the acting Attorney General "hereby order[s] that FDA-approved drug products containing marijuana, as well marijuana in any form covered by a state medical marijuana license,
Most commentary on the “hemp ban” included in the November funding bill has focused on two related questions: (1) which products and activities may become unlawful on November 12, 2026; and (2) whether Congress will materially amend or delay the ban before then. I recently discussed another consequence operators should be considering as the deadline
Earlier this month, the Bailiwick of Jersey appeared poised to take a measured, evidence-based step toward re-examining its approach to non-medical cannabis. Three reform proposals put forward by Tom Binet, Minister for Health and Social Services, were expected to be debated by the States Assembly of Jersey on February 3, 2026. That debate has now
Most commentary on the “hemp ban” included in the November funding bill has focused on two, related considerations: (1) which products and activities will become unlawful on November 12, 2026, and (2) whether Congress will materially amend, or delay, the ban before then. While that focus is understandable, it overlooks a critical, and more immediate,
Harris Sliwoski attorney Jason Adelstone will be participating in CannaGen Sesh 3: Deeply Seeded, a webinar hosted by CannaGen on Thursday, January 22, from 11:00–12:00 PM PST. This session will focus on a significant but underappreciated change in federal hemp law that will materially affect cannabis genetics, seed commerce, and cross-border operations. Under recent amendments
What long resembled a Never Ending Story has finally reached a turning point. Today, President Trump signed an Executive Order directing the Attorney General to reschedule marijuana as a Schedule III substance under the Controlled Substances Act (CSA). The signing and remarks can be viewed here. The order includes the following directives (as first reported
Even with slightly lighter attendance at MjBizCon this year, the quality of conversations and the overall engagement felt stronger than ever. The insights, candor, and determination that filled the hallways and side events were a powerful reminder of why this industry keeps pushing forward despite constant headwinds. The event team delivered a well-run, thoughtful conference
